Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yichen Sun

Showing results (61-70 of 67) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 67 results.
The Journal of Clinical Investigation|August 31, 2021
Targeting enhancer reprogramming to mitigate MEK inhibitor resistance in preclinical models of advanced ovarian cancerShini Liu, Qiong Zou, Jie-Ping Chen, et al.
Cancer Letters|September 5, 2021
CREBBP cooperates with the cell cycle machinery to attenuate chidamide sensitivity in relapsed/refractory diffuse large B-cell lymphomaYichen Sun, Yan Gao, Jianfeng Chen, et al.
Nature Communications|April 11, 2024
Nardilysin-regulated scission mechanism activates polo-like kinase 3 to suppress the development of pancreatic cancerJie Fu, Jianhua Ling, Ching-Fei Li, et al.
Clinical Epigenetics|February 5, 2023
Aberrant JAK-STAT signaling-mediated chromatin remodeling impairs the sensitivity of NK/T-cell lymphoma to chidamideJinghong Chen, Zhixiang Zuo, Yan Gao, et al.
Gut|December 5, 2023
Integrative multiomics enhancer activity profiling identifies therapeutic vulnerabilities in cholangiocarcinoma of different etiologiesJing Han Hong, Chern Han Yong, Hong Lee Heng, et al.
Scientific Data|July 12, 2024
Genetic and multi-omic resources for Alzheimer disease and related dementia from the Knight Alzheimer Disease Research CenterMaria Victoria Fernandez, Menghan Liu, Aleksandra Beric, et al.
Science Translational Medicine|April 1, 2026
Uncovering BAP1 deubiquitination landscape enhances mechanism elucidation and therapeutic precision for BAP1-deficient pancancersJing Han Hong, Chern Han Yong, Hong Lee Heng, et al.
Pageof 7

Showing results (61-70 of 67) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 67 results.
The Journal of Clinical Investigation|August 31, 2021
Targeting enhancer reprogramming to mitigate MEK inhibitor resistance in preclinical models of advanced ovarian cancerShini Liu, Qiong Zou, Jie-Ping Chen, et al.
Cancer Letters|September 5, 2021
CREBBP cooperates with the cell cycle machinery to attenuate chidamide sensitivity in relapsed/refractory diffuse large B-cell lymphomaYichen Sun, Yan Gao, Jianfeng Chen, et al.
Nature Communications|April 11, 2024
Nardilysin-regulated scission mechanism activates polo-like kinase 3 to suppress the development of pancreatic cancerJie Fu, Jianhua Ling, Ching-Fei Li, et al.
Clinical Epigenetics|February 5, 2023
Aberrant JAK-STAT signaling-mediated chromatin remodeling impairs the sensitivity of NK/T-cell lymphoma to chidamideJinghong Chen, Zhixiang Zuo, Yan Gao, et al.
Gut|December 5, 2023
Integrative multiomics enhancer activity profiling identifies therapeutic vulnerabilities in cholangiocarcinoma of different etiologiesJing Han Hong, Chern Han Yong, Hong Lee Heng, et al.
Scientific Data|July 12, 2024
Genetic and multi-omic resources for Alzheimer disease and related dementia from the Knight Alzheimer Disease Research CenterMaria Victoria Fernandez, Menghan Liu, Aleksandra Beric, et al.
Science Translational Medicine|April 1, 2026
Uncovering BAP1 deubiquitination landscape enhances mechanism elucidation and therapeutic precision for BAP1-deficient pancancersJing Han Hong, Chern Han Yong, Hong Lee Heng, et al.
Pageof 7